成纖維細胞生長因子23(FGF23)重組蛋白
Recombinant Fibroblast Growth Factor 23 (FGF23)
ADHR; HYPF; HPDR2; PHPTC; Phosphatonin; Tumor-derived hypophosphatemia-inducing factor
- 編號RPA746Hu04
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預(yù)測分子量54.9kDa
- 實際分子量58kDa(差異分析請參閱說明書)
- 片段與標簽Tyr25~Ile251 with N-terminal His and GST Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點8.9
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 840¥ 2100¥ 4200¥ 12600¥ 31500
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA746Hu01 | 成纖維細胞生長因子23(FGF23)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA746Hu02 | 成纖維細胞生長因子23(FGF23)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA746Hu03 | 成纖維細胞生長因子23(FGF23)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA746Hu03 | 成纖維細胞生長因子23(FGF23)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA746Hu04 | 成纖維細胞生長因子23(FGF23)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA746Hu01 | 成纖維細胞生長因子23(FGF23)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA746Hu02 | 成纖維細胞生長因子23(FGF23)多克隆抗體 | WB,IHC. |
| PAA746Hu03 | 成纖維細胞生長因子23(FGF23)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA746Hu04 | 成纖維細胞生長因子23(FGF23)多克隆抗體 | WB |
| PAA746Hu01 | 成纖維細胞生長因子23(FGF23)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA746Hu71 | 成纖維細胞生長因子23(FGF23)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| RAA746Hu21 | 成纖維細胞生長因子23(FGF23)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
| MAA746Hu23 | 成纖維細胞生長因子23(FGF23)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA746Hu22 | 成纖維細胞生長因子23(FGF23)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA746Hu21 | 成纖維細胞生長因子23(FGF23)單克隆抗體 | WB |
| LAA746Hu72 | 成纖維細胞生長因子23(FGF23)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| MEA746Hu | 成纖維細胞生長因子23(FGF23)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEA746Hu | 成纖維細胞生長因子23(FGF23)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA746Hu | 成纖維細胞生長因子23(FGF23)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Journal of international medicine | Prognostic impact of renal function in precapillary pulmonary hypertension[Pubmed: 24011362] |
| BMC Nephrology | FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients[Pubmed: 24180481] |
| Journal of Clinical Densitometry | Lower Fibroblast Growth Factor 23 Levels in Young Adults With Crohn Disease as a Possible Secondary Compensatory Effect on the Disturbance of Bone and Mineral Metabolism[Pubmed: 23623649] |
| J Intern Med. | Prognostic impact of renal function in precapillary pulmonary hypertension.[Pubmed:24011362] |
| Journal of Bone and Mineral Research | Adverse effects of osteocytic constitutive activation of ?-catenin on bone strength and bone growth[Pubmed:25639729] |
| Nefrologia | Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation El factor de crecimiento fibroblástico está asociado con el índice de masa ventricular izquierda, anemia y niveles bajos de saturación de la transferrina[PubMed: 26394828] |
| Medicine (Baltimore) | An Attempt to Evaluate Selected Aspects of “Bone–Fat Axis” Function in Healthy Individuals and Patients With Pancreatic Cancer[PubMed: 26266370] |
| Ann Biol Clin (Paris) | Les biomarqueurs des calcifications vasculaires: quelles limites analytiques pour leur transfert de la recherche bioclinique à la pratique?[PubMed: 26069069] |
| Scandinavian Journal of Gastroenterology | High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23[Pubmed:27326766] |
| PLOS?ONE | Prostaglandin-E2?Mediated?Increase?in?Calcium?and?Phosphate?Excretion?in a?Mouse?Model?ofDistal?Nephron?Salt?Wasting.[pubmed:27442254] |
| Journal of Laboratory Diagnostics | Evaluation of concentration fibroblast growth factor FGF-23 in hemodialysed patients and after kidney transplantation[publication:312592751] |
| Journal of Integrative Nephrology & Andrology | Associations between serum fibroblast growth factor 23 level and intradialytic hypotension in hemodialysis patients[issn:2394-2916] |
| Journal of Renal Nutrition | ADAM17, a New Player in the Pathogenesis of Chronic Kidney Disease-Mineral and Bone Disorder.[pubmed:29056164] |
| Experimental Biology and Medicine(Maywood) | Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats[Pubmed:29763365] |
| Psychiatry Research | Cerebrospinal fluid FGF23 levels correlate with a measure of impulsivity[Pubmed:29677623] |
| BMC?Pediatrics | Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children[Pubmed:29907141] |
| Medical Science Monitor | Effect of Salt Intervention on Serum Levels of Fibroblast Growth Factor 23 (FGF23) in Chinese Adults: An Intervention Study[Pubmed:29608553] |
| International Journal of Chronic Obstructive Pulmonary Disease | Disconnection of pulmonary and systemic arterial stiffness in COPD[Pubmed:29881265] |
| Saudi?journal of?kidney?diseases and transplantation | Prevalence of cardiac arrhythmia and risk factors in chronic kidney disease patients[Pubmed:29970732] |
| Nephrology Dialysis?Transplantation | High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease[Pubmed: 30189026] |
| BioFactors? | Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma[Pubmed: 30334297] |
| Biological?Trace?Element?Research | Altered Mineral Metabolism and Disequilibrium Between Calcification Promoters and Inhibitors in Chronic Hemodialysis Patients[Pubmed: 30847765] |
| Clin Implant Dent Relat Res. | Evaluation of FGF‐23 and 25(OH)D3 levels in peri‐implant sulcus fluid in peri‐implant health and diseases[Pubmed: 31407857] |
| JACC-Cardiovascular Imaging | PREVALANCE AND PROGRESSION OF CARDIOVASCULAR CALCIFICATIONS IN HAEMODIALYSIS PATIENTS[Pubmed: 28797410] |
| Saudi J Kidney Dis Transpl | Serum fibroblast growth factor 23 levels do not correlate with carotid intima-media thickness in patients with chronic kidney disease[Pubmed: 31696838] |
| Biomedicine & Pharmacotherapy | MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7[Pubmed: 31918268] |
| Is Serum FGF-23 Associated with Subclinic Atherosclerosis in Patients with AA Amyloidosis?[] | |
| THE RELATIONSHIP BETWEEN ARTERIAL STIFNESS AND 25-(OH) VITAMIN D, FGF 23 IN MAINTENANCE HEMODIALYSIS PATIENTS[] | |
| THE RELATIONSHIP BETWEEN ARTERIAL STIFFNESS AND 25-(OH) VITAMIN D, FGF 23 IN MAINTENANCE HEMODIALYSIS PATIENTS KRON?K ?-[] | |
| Calcif Tissue Int | The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations[Pubmed:35665817] |
| European Journal of Medical Genetics | Genetic and clinical profile of patients with hypophosphatemic rickets[Pubmed:35738466] |
| African Health Sciences | Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease[] |